8 January 2018
Micro Focus International plc
Presentation of the interim results for the six months ended 31 October 2017
Micro Focus International plc (LSE: MCRO.L, NYSE: MFGP), the global enterprise software product group, confirms that the presentation of the interim results for the six months ended 31 October 2017 will be held today at 9am GMT in London.
A live webcast and recording of the presentation will be available at https://investors.microfocus.com/ during and after the event.
Micro Focus Tel: +44 (0) 1635 565200
Kevin Loosemore, Executive Chairman
Chis Hsu, Chief Executive
Tim Brill, IR Director
Powerscourt (PR adviser) Tel: +44 (0) 20 7250 1446
About Micro Focus
Micro Focus (LSE: MCRO.L, NYSE: MFGP) is a global enterprise software Company supporting the technology needs and challenges of the Global 2000. Our solutions help organizations leverage existing IT investments, enterprise applications and emerging technologies to address complex, rapidly evolving business requirements while protecting corporate information at all times. Our product portfolios are Micro Focus (which included HPE Software from completion) and SUSE. Within Micro Focus our solution portfolios are COBOL Development and Mainframe Solutions, Host Connectivity, Identity and Access Security, IT Development and Operations Management Tools, and Collaboration and Networking. Within HPE Software our solution portfolios are IT Operation Management, Application Delivery Management, Enterprise Security Product, Platform, and Information Management Business. With effect from 1 November 2017 the Micro Focus solution portfolios are Security, IT Operations Management, Application Delivery Management, Information Management & Governance and Application Modernization & Connectivity. For more information, visit: www.microfocus.com. SUSE, a pioneer in Open Source software, provides reliable, interoperable Linux, Software Defined Infrastructure and Application Delivery platforms that give customers greater control and flexibility while reducing cost. For more information, visit: www.suse.com.
This information is provided by RNS